Table 2 TMS parameters of patients with multiple sclerosis and controls

UL CL (ms)

Controls

20.18 ± 1.84

19.79 ± 1.73

0.441

Patients

24.65 ± 3.94

25.28 ± 5.41

0.604

UL MEP amplitude (mV)

Controls

4.34 ± 2.89

4.03 ± 2.81

0.695

Patients

1.76 ± 1.92

1.39 ± 1.04

0.393

UL RL (ms)

Controls

12.18 ± 1.53

12.28 ± 1.4

0.807

Patients

13.05 ± 2.2

12.76 ± 1.76

0.504

UL CMCT (ms)

Controls

7.99 ± 1.64

7.53 ± 1.4

0.218

Patients

11.53 ± 3.6

12.2 ± 5.0

0.58

UL CMCT-f (ms)

Controls

6.8 ± 1.35

6.82 ± 1.9

0.96

Patients

10.56 ± 3.6

11.23 ± 4.82

0.52

LL CL (ms)

Controls

37.32 ± 4.04

37.31 ± 3.47

0.997

Patients

49.51 ± 15.1

50.51 ± 11.04

0.80

LL MEP amplitude (mV)

Controls

1.13 ± 0.23

1.61 ± 1.12

0.132

Patients

0.68 ± 0.55

0.8 ± 0.47

0.432

LL RL (ms)

Controls

22.34 ± 2.95

22.03 ± 2.7

0.696

Patients

24.28 ± 4.05

23.33 ± 2.96

0.364

LL CMCT (ms)

Controls

14.88 ± 3.1

15.19 ± 2.91

0.714

Patients

27.4 ± 11.44

27.57 ± 10.33

0.966

LL CMCT-f (ms)

Controls

12.09 ± 2.51

12.54 ± 2.66

0.534

Patients

25.51 ± 10.69

22.36 ± 11.08

0.333